Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS: an Open-label, Non-randomized Controlled Clinical Study

NCT05872425 is registered in ClinicalTrials.gov with Guangdong Women and Children Hospital as lead sponsor.

NCT NCT05872425
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05872425 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Dingkundan Combined With Combination Oral Contraceptives in the Treatment of PCOS: an Open-label, Non-randomized Controlled Clinical Study
Lead sponsor
Guangdong Women and Children Hospital
Phase
Not applicable
Overall status
Completed
Start date
February 1, 2023
Completion date
April 1, 2024
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcos